Purchases and Sales Made in Q3 2021 in Monopar Therapeutics (MNPR)
This table provides information about the institutional ownership of Monopar Therapeutics (MNPR) during Q3 2021. The information is specifically focused on institutions that hold shares of Monopar Therapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2021
Q3 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
10.4K+ 36.19% |
$46.8K - $62.5K
|
39.2K
$1.9M
|
|
|
Nov 15, 2021
Q3 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
4KNew |
$18K - $24K
|
4K
$194K
|
|
|
Nov 12, 2021
Q3 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
2.42K+ 2.48% |
$10.9K - $14.5K
|
99.9K
$4.84M
|
|
|
Mar 22, 2023
Q3 2021
|
American Portfolios Advisors
Holbrook, NY |
BUY
|
- |
700New |
$3.15K - $4.2K
|
700
$34K
|
|
|
Nov 15, 2021
Q3 2021
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
233+ 0.65% |
$1.05K - $1.4K
|
36.3K
$1.76M
|
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1- 3.7% |
$4.5 - $6
|
26
$1.26K
|
|
|
Oct 29, 2021
Q3 2021
|
Paragon Wealth Strategies, LLC
|
SELL
|
- |
-58Closed |
$261 - $348
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-1.01K- 19.77% |
$4.56K - $6.08K
|
4.12K
$200K
|
|
|
Nov 09, 2021
Q3 2021
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.08K- 7.18% |
$4.86K - $6.49K
|
14K
$677K
|